Alternate Health

Alternate Health R&D Expenses

The Research & Development Expenses of Alternate Health (AHGIF) as of Nov 6, 2026 is 484,900.00 CAD. In the previous year, Research & Development Expenses was 506,900.00 CAD — a change of -4.34% (lower).

R&D Expenses

484,900.00CAD

YoY

-4.34%

Last updated:

Research & Development Expenses of Alternate Health is 2018 484,900.00 CAD. Research & Development Expenses of Alternate Health was 2017 506,900.00 CAD. It decreases by -4.34% lower compared to the previous year.

The Alternate Health R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2017
506,900.00 CAD
Jan 1, 2018
484,900.00 CAD
The Alternate Health R&D Expenses history
YEARR&D ExpensesYoY
484,900.00CAD-4.34%
506,900.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alternate Health Stock analysis

What does Alternate Health do? Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs. Alternate Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alternate Health stock

Research & Development Expenses of Alternate Health is 484,900.00 CAD in 2018.

Research & Development Expenses of Alternate Health changed from 506,900.00 CAD to 484,900.00 CAD, representing a -4.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Alternate Health since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Alternate Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Alternate Health

All Key Metrics — Alternate Health